Amanote Research
Register
Sign In
Modelling Cost Effectiveness of Meningococcal Serogroup C Conjugate Vaccination Campaign in England and Wales
BMJ
doi 10.1136/bmj.324.7341.809
Full Text
Open PDF
Abstract
Available in
full text
Date
April 6, 2002
Authors
C. L Trotter
Publisher
BMJ
Related search
Maintenance of Immune Response Throughout Childhood Following Serogroup C Meningococcal Conjugate Vaccination in Early Childhood
Archives of Disease in Childhood
Child Health
Pediatrics
Perinatology
Pin103 - A Systematic Review: Cost-Effectiveness of Vaccination With New Meningococcal Serogroup B Vaccines
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Antibody Persistence in Australian Adolescents Following Meningococcal C Conjugate Vaccination
Pediatric Infectious Disease Journal
Child Health
Infectious Diseases
Pediatrics
Perinatology
Microbiology
Impact of Serogroup a Meningococcal Conjugate Vaccine for Africa
Human Vaccines and Immunotherapeutics
Medicine
Allergy
Immunology
Pharmacology
Effects of Prior Polysaccharide Vaccination on Magnitude, Duration, and Quality of Immune Responses to and Safety Profile of a Meningococcal Serogroup C Tetanus Toxoid Conjugate Vaccination in Adults
Clinical Diagnostic Laboratory Immunology
7-Valent Pneumococcal Conjugate Vaccination in England and Wales: Is It Still Beneficial Despite High Levels of Serotype Replacement?
PLoS ONE
Multidisciplinary
Cost Effectiveness of Trifluridine/Tipiracil for Previously Treated Metastatic Colorectal Cancer in England and Wales
Clinical Colorectal Cancer
Oncology
Gastroenterology
Temporal Associations Between National Outbreaks of Meningococcal Serogroup W and C Disease in the Netherlands and England: An Observational Cohort Study
The Lancet Public Health
Environmental
Public Health
Occupational Health
The Future of BCG Vaccination in Schools in England and Wales.
BMJ
